IT1295954B1 - Utilizzo di un agente chimico per diminuire le variazioni di giro di vita e l'effetto di costipazione legato all'assunzione di altri agenti - Google Patents

Utilizzo di un agente chimico per diminuire le variazioni di giro di vita e l'effetto di costipazione legato all'assunzione di altri agenti

Info

Publication number
IT1295954B1
IT1295954B1 IT97TO000974A ITTO970974A IT1295954B1 IT 1295954 B1 IT1295954 B1 IT 1295954B1 IT 97TO000974 A IT97TO000974 A IT 97TO000974A IT TO970974 A ITTO970974 A IT TO970974A IT 1295954 B1 IT1295954 B1 IT 1295954B1
Authority
IT
Italy
Prior art keywords
agents
chemical agent
recruitment
decrease
variations
Prior art date
Application number
IT97TO000974A
Other languages
English (en)
Inventor
Andre Salkin
Original Assignee
Andre Salkin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9613646A external-priority patent/FR2762215A1/fr
Priority claimed from FR9709559A external-priority patent/FR2762216B1/fr
Priority claimed from FR9709701A external-priority patent/FR2766369B1/fr
Application filed by Andre Salkin filed Critical Andre Salkin
Publication of ITTO970974A0 publication Critical patent/ITTO970974A0/it
Publication of ITTO970974A1 publication Critical patent/ITTO970974A1/it
Application granted granted Critical
Publication of IT1295954B1 publication Critical patent/IT1295954B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/29—Mineral substances, e.g. mineral oils or clays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Steroid Compounds (AREA)
  • Graft Or Block Polymers (AREA)
  • Photoreceptors In Electrophotography (AREA)
IT97TO000974A 1996-11-08 1997-11-07 Utilizzo di un agente chimico per diminuire le variazioni di giro di vita e l'effetto di costipazione legato all'assunzione di altri agenti IT1295954B1 (it)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9613646A FR2762215A1 (fr) 1996-11-08 1996-11-08 Utilisation d'un agent chimique pour diminuer l'effet de constipation et le tour de taille
FR9707693 1997-06-20
FR9709559A FR2762216B1 (fr) 1997-07-28 1997-07-28 Utilisation d'un agent chimique pour diminuer l'effet de constipation et le tour de taille
FR9709701A FR2766369B1 (fr) 1997-07-28 1997-07-30 Utilisation d'un agent chimique pour diminuer l'effet de constipation et le tour de taille

Publications (3)

Publication Number Publication Date
ITTO970974A0 ITTO970974A0 (it) 1997-11-07
ITTO970974A1 ITTO970974A1 (it) 1999-05-07
IT1295954B1 true IT1295954B1 (it) 1999-05-28

Family

ID=27446984

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97TO000974A IT1295954B1 (it) 1996-11-08 1997-11-07 Utilizzo di un agente chimico per diminuire le variazioni di giro di vita e l'effetto di costipazione legato all'assunzione di altri agenti

Country Status (12)

Country Link
US (1) US5948824A (it)
EP (1) EP0959892B1 (it)
JP (1) JP2000514465A (it)
AT (1) ATE232734T1 (it)
AU (1) AU5058698A (it)
BE (1) BE1011385A3 (it)
CA (1) CA2270943A1 (it)
CH (1) CH692467A5 (it)
DE (1) DE69719218D1 (it)
IT (1) IT1295954B1 (it)
NL (1) NL1007491C2 (it)
WO (1) WO1998020883A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811553B1 (fr) 2000-07-12 2002-09-13 Oreal Compositions contenant des composes du type sel de flavylium non substitues en position 3 pour la coloration de la peau et une silicone organomodifiee
US6428822B1 (en) 2001-04-03 2002-08-06 Chengzhi Life Science Company, Ltd. Extracts of mixed arctium lappa L., carrot and whole radish for treating hypertension, constipation and detoxification
DE10120428A1 (de) * 2001-04-26 2002-10-31 Thomas Gieselmann Orales Mittel für die Human- und Veterinärmedizin
US20030022206A1 (en) * 2001-05-16 2003-01-30 Kay Robert A. Method of characterizing a homeopathic preparation
JP5298942B2 (ja) * 2008-02-26 2013-09-25 大正製薬株式会社 飲料

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273209B1 (en) * 1986-12-30 1992-01-15 American Cyanamid Company Composition of matter containing polycarbophil
US5516524A (en) * 1993-12-20 1996-05-14 The Procter & Gamble Company Laxative compositions containing bulk fiber
US5418220A (en) * 1994-03-08 1995-05-23 Schmidt; Alfred Method for treating constipation using dimethicone
JP3836893B2 (ja) * 1995-01-24 2006-10-25 アボットジャパン株式会社 ポリカルボフィルカルシウム含有製剤

Also Published As

Publication number Publication date
ATE232734T1 (de) 2003-03-15
WO1998020883A1 (fr) 1998-05-22
EP0959892B1 (fr) 2003-02-19
AU5058698A (en) 1998-06-03
CA2270943A1 (fr) 1998-05-22
NL1007491A1 (nl) 1998-05-14
US5948824A (en) 1999-09-07
NL1007491C2 (nl) 1999-04-23
EP0959892A1 (fr) 1999-12-01
ITTO970974A1 (it) 1999-05-07
ITTO970974A0 (it) 1997-11-07
CH692467A5 (fr) 2002-07-15
DE69719218D1 (de) 2003-03-27
JP2000514465A (ja) 2000-10-31
BE1011385A3 (fr) 1999-08-03

Similar Documents

Publication Publication Date Title
DE69905368D1 (en) Oxydiertes thymosin beta 4
BG105783A (en) Triazole compounds with dopamine-d3-receptor affinity
PL308217A1 (en) Derivatives of 1-(oxo-acetyl)-piperidine-2-carboxylic as agents sensibilising multiple-drug-resistant cancer cells
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
GB0225474D0 (en) Therapeutic agents
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
TR200000009T2 (tr) Triazol bileşikleri ve bunların dopamin-D3-ligandları olarak kullanımları.
BR0308904A (pt) Método de tratamento de gastroparesia, e, uso de um composto de glp-1
DE69717148D1 (de) 3-pyridylenantiomere und ihre verwendung als analgetika
BG106104A (en) Method for the treatment of diseases related to increased number of neutrophils or neutrophil overactivation
ATE206708T1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
KR950010891A (ko) 내성 종양을 치료하는 방법
GB2380939B (en) Treatment or prevention of auto-immune diseases
MX9505192A (es) Utilizacion de un antagonista de la substancia p para la obtencion de composiciones farmaceuticas para el tratamiento del enrojecimiento cutaneo de origen neurogenico.
FI970469A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
ATE40822T1 (de) Aromatase-hemmende 1,2,3-triazol-1-yl-, tetrazol- 1-yl- und tetrazol-2-yl-verbindungen.
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
PT821588E (pt) Levobupivacaina e sua utilizacao como anestesico em mulheres gravidas
MX9709466A (es) Medicamento para inhibir el melanoma.
ATE37714T1 (de) Imidazolyl-, triazolyl- und tetrazolylverbindungen.
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
ES2154290T3 (es) Estimulacion de la diferenciacion celular por sindecano.
DE69719218D1 (de) Verwendung von pvp oder povidone zum reduzieren von darmschwellungen
SE9802538D0 (sv) New pharmaceutically active compounds

Legal Events

Date Code Title Description
0001 Granted